FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention discloses applying 3-{[α-isobutanoyloxyethoxy)carbonyl]aminomethyl}-5-methyl-hexanoic acid or its pharmaceutically acceptable salt in preparing a drug for treating or preventing restless leg syndrome in a patient or for improving sleep in a patient suffering restless leg syndrome. There are also described pharmaceutical compositions for treating or preventing restless leg syndrome and for improving sleep in a patient with restless leg syndrome, containing a therapeutically effective amount of 3-{[α-isobutanoyloxyethoxy)carbonyl]aminomethyl}-5-methyl-hexanoic acid or its pharmaceutically acceptable salt.
EFFECT: preparing the pharmaceutical compositions for treating or preventing restless leg syndrome and improving sleep in a patient with restless leg syndrome.
31 cl, 3 ex
| Title |
Year |
Author |
Number |
| TREATMENT OR PREVENTION OF RESTLESS LEGS SYNDROME WITH USING PROMEDICINES OF GABA ANALOGUES |
2004 |
- Barret Ronal'D V.
- Kenafaks Daniel' M.
|
RU2377234C2 |
| Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER |
2010 |
- Khotosi Jasumiti
- Kholland Sasha
- Pajjan Donal'D Dzh.
|
RU2555326C2 |
| CYCLIC UREAS, METHOD OF INHIBITION OF RETROVIRUS GROWTH AND PHARMACEUTICAL COMPOSITION |
1992 |
- Patrik Juk-Sun Lehm
- Charl'Z Dzhozef Ajrmehnn
- Karl Nikolas Khodzh
- Prabkhakar Kondadzhi Dzhadkhav
- Dzhordzh Vinsent Delukka
|
RU2131420C1 |
| PROTEIN TYROSINE KINASE RECEPTOR INHIBITOR COMPOSITIONS |
2009 |
- U Dzhej Tsze-Tsyan
- Van Lin
|
RU2586212C2 |
| TYPE 1 DIACYLGLYCEROL-O-ACYLTRANSFERASE ENZYME INHIBITORS |
2008 |
- Lju Gan
- Sin' Chzhili
- Kim Filip R.
- Sauehrs Ehndrju Dzh.
|
RU2486186C2 |
| LEVODOP PRODRUGS, BASED ON THEM COMPOSITIONS AND THEIR APPLICATION |
2005 |
- Sjan Tszja-Nin
- Gellop Mark A.
- Chzhou Sindi S.
- Ngujen Mark
- Daj Sjuehdun
- Li Tszjan'Khua
- Kandi Kennet K.
- Dzhambe Nel'Son L.
|
RU2365580C2 |
| PYRIMIDINE-SUBSTITUTED PURINE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THEREON, METHOD OF PROTEIN KINASE INHIBITION, METHOD OF TREATING OR PREVENTING DISEASES SENSITIVE TO PROTEIN KINASE INHIBITION AND METHOD OF TREATING PROLIFERATIVE DISEASES |
2008 |
- Nagaradzh Kharish Kumar Majsur
- Uil'Jams Meredit
|
RU2518098C2 |
| PYRIMIDINE-SUBSTITUTED DERIVATIVES OF PURINE, PHARMACEUTICAL COMPOSITION BASED THEREON, METHOD FOR INHIBITING PROTEIN KINASE, METHOD FOR TREATMENT OR PREVENTION OF DISEASES SUSCEPTIBLE TO INHIBITING PROTEIN KINASE, AND METHOD OF TREATING PROLIFERATIVE DISEASES |
2008 |
- Nagaradzh Kharish Kumar Majsur
- Uilyams Meredit
|
RU2681081C2 |
| COMPOSITIONS, SYNTHESIS AND METHODS OF APPLYING ARYLPIPERAZINE DERIVATIVES |
2010 |
- Bkhat Laksminarajan
- Mokhapatra Prabkhu Prasad
- Adiej Kouakou
|
RU2506262C2 |
| SUBSTITUTED QUINOLINE DERIVATIVES AS MITOTIC KINESIN INHIBITORS |
2005 |
- Vehng Vejbo
- Konstehntajn Rajan
- Lehgnajton Lajehna Mehri
- Behar Kennet
|
RU2385867C2 |
